PDF herunterladen
Am J Perinatol 2015; 32(02): 163-170
DOI: 10.1055/s-0034-1378144
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Pilot Randomized, Controlled Trial of Metformin versus Insulin in Women with Type 2 Diabetes Mellitus during Pregnancy

Jerrie S. Refuerzo
1   Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Health Science Center at Houston, Houston, Texas
,
Rose Gowen
2   Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Health Science Center at Brownsville, Brownsville, Texas
,
Claudia Pedroza
3   Center for Clinical Research and Evidence-Based Medicine, University of Texas Health Science Center at Houston, Houston, Texas
,
Maria Hutchinson
1   Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Health Science Center at Houston, Houston, Texas
,
Sean C. Blackwell
1   Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Health Science Center at Houston, Houston, Texas
,
Susan Ramin
4   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
› Institutsangaben
Weitere Informationen

Publikationsverlauf

11. Januar 2014

16. April 2014

Publikationsdatum:
04. Juni 2014 (online)

    Lizenzen und Reprints

Abstract

Objective Few studies support oral diabetic treatment in pregnant women with type 2 diabetes mellitus (T2DM). The objective of this study was to compare the effects of metformin versus insulin on achieving glycemic control and improving maternal and neonatal outcomes in pregnant women with T2DM.

Study Design A pilot randomized, controlled trial was conducted of metformin versus insulin for the treatment of T2DM during pregnancy. The primary outcome was glycemic control measured with hemoglobin A1c < 7% at delivery. Maternal and neonatal outcomes were compared between groups.

Results In this study, 8 women received metformin and 11 received insulin. All women in both groups achieved glycemic control by delivery (HgbA1c: metformin 5.96 ± 5.88 vs. insulin 6.34 ± 0.92%). There were similar rates of cesarean delivery, birth weights, neonatal intensive care unit admissions, respiratory distress syndrome, and neonatal dextrose treatment between groups. There was one case of fetal macrosomia in the insulin group, one case of shoulder dystocia in the metformin group and no cases of failed metformin therapy.

Conclusion In this pilot study, glycemic control was achieved in women who received metformin and insulin. Larger studies are needed to determine whether metformin can be considered a reasonable alternative to insulin in pregnant women with T2DM.

Keywords

type 2 diabetes mellitus - pregnancy - metformin
 

  • References

  • 1 Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288 (14) 1723-1727
    CrossrefPubMedGoogle Scholar
  • 2 Checa MA, Requena A, Salvador C , et al; Reproductive Endocrinology Interest Group of the Spanish Society of Fertility. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome. Hum Reprod Update 2005; 11 (4) 375-390
    CrossrefPubMedGoogle Scholar
  • 3 Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005; 65 (3) 385-411
    CrossrefPubMedGoogle Scholar
  • 4 Krentz AJ, Ferner RE, Bailey CJ. Comparative tolerability profiles of oral antidiabetic agents. Drug Saf 1994; 11 (4) 223-241
    CrossrefPubMedGoogle Scholar
  • 5 Goodarzi MO, BryerAsh M. Metformin revisited: reevaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes Obes Metab 2005; 7 (6) 654-665
    CrossrefPubMedGoogle Scholar
  • 6 Norman RJ, Wang JX, Hague W. Should we continue or stop insulin sensitizing drugs during pregnancy?. Curr Opin Obstet Gynecol 2004; 16 (3) 245-250
    CrossrefPubMedGoogle Scholar
  • 7 Klip A, Leiter LA. Cellular mechanism of action of metformin. Diabetes Care 1990; 13 (6) 696-704
    CrossrefPubMedGoogle Scholar
  • 8 Gestational diabetes mellitus. Practice Bulletin No. 137. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013; 122: 406-416
    CrossrefPubMedGoogle Scholar
  • 9 Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 2003; 102 (4) 857-868
    Google Scholar
  • 10 Martorell R, Stein AD, Schroeder DG. Early nutrition and later adiposity. J Nutr 2001; 131 (3) 874S-880S
    CrossrefPubMedGoogle Scholar
  • 11 Strauss RS. Effects of the intrauterine environment on childhood growth. Br Med Bull 1997; 53 (1) 81-95
    CrossrefPubMedGoogle Scholar
  • 12 Whitaker RC, Dietz WH. Role of the prenatal environment in the development of obesity. J Pediatr 1998; 132 (5) 768-776
    CrossrefPubMedGoogle Scholar
  • 13 Jovanovic R, Jovanovic L. Obstetric management when normoglycemia is maintained in diabetic pregnant women with vascular compromise. Am J Obstet Gynecol 1984; 149 (6) 617-623
    CrossrefPubMedGoogle Scholar
  • 14 Glueck CJ, Goldenberg N, Streicher P, Wang P. Metformin and gestational diabetes. Curr Diab Rep 2003; 3 (4) 303-312
    CrossrefPubMedGoogle Scholar
  • 15 Glueck CJ, Goldenberg N, Streicher P, Wang P. The contentious nature of gestational diabetes: diet, insulin, glyburide and metformin. Expert Opin Pharmacother 2002; 3 (11) 1557-1568
    CrossrefPubMedGoogle Scholar
  • 16 Simmons D, Walters BN, Rowan JA, McIntyre HD. Metformin therapy and diabetes in pregnancy. Med J Aust 2004; 180 (9) 462-464
    CrossrefPubMedGoogle Scholar
  • 17 Lawrence JM, Andrade SE, Avalos LA , et al; Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP) Study Group. Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007. Obstet Gynecol 2013; 121 (1) 106-114
    CrossrefPubMedGoogle Scholar
  • 18 Coetzee EJ, Jackson WP. Pregnancy in established non-insulin-dependent diabetics. A five-and-a-half year study at Groote Schuur Hospital. S Afr Med J 1980; 58 (20) 795-802
    PubMedGoogle Scholar
  • 19 Ibrahim MI, Hamdy A, Shafik A, Taha S, Anwar M, Faris M. The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial. Arch Gynecol Obstet 2014; 289 (5) 959-965
    CrossrefPubMedGoogle Scholar
  • 20 Hickman MA, McBride R, Boggess KA, Strauss R. Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. Am J Perinatol 2013; 30 (6) 483-490
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 21 Lilford RJ, Thornton JG, Braunholtz D. Clinical trials and rare diseases: a way out of a conundrum. BMJ 1995; 311 (7020) 1621-1625
    CrossrefPubMedGoogle Scholar
  • 22 Wijeysundera DN, Austin PC, Hux JE, Beattie WS, Laupacis A. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. J Clin Epidemiol 2009; 62 (1) 13-21 , e5
    CrossrefPubMedGoogle Scholar
  • 23 Goodman SN. Introduction to Bayesian methods I: measuring the strength of evidence. Clin Trials 2005; 2 (4) 282-290 , discussion 301–304, 364–378
    CrossrefPubMedGoogle Scholar
  • 24 Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000; 343 (16) 1134-1138
    CrossrefPubMedGoogle Scholar
  • 25 Coetzee EJ, Jackson WP. Oral hypoglycaemics in the first trimester and fetal outcome. S Afr Med J 1984; 65 (16) 635-637
    PubMedGoogle Scholar
  • 26 Coetzee EJ, Jackson WP. The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Pract 1985– 1986; 1 (5) 281-287
    PubMedGoogle Scholar
  • 27 Rowan JA, Hague WM, Gao W, Battin MR, Moore MP ; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008; 358 (19) 2003-2015
    CrossrefPubMedGoogle Scholar
  • 28 Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004; 19 (8) 1734-1740
    CrossrefPubMedGoogle Scholar
  • 29 Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002; 17 (11) 2858-2864
    CrossrefPubMedGoogle Scholar